Valuation: MiniMed Group, Inc.

Market Cap 6.12B 5.34B 5.04B 4.58B 8.58B 588B 8.62B 60.41B 23.31B 299B 23.01B 22.5B 961B P/E 2027 *
36.2x
P/E 2028 * 29.1x
Enterprise Value 5.83B 5.08B 4.8B 4.36B 8.16B 559B 8.2B 57.48B 22.18B 284B 21.89B 21.41B 915B EV / Sales 2027 *
1.7x
EV / Sales 2028 * 1.48x
Free-Float
10.08%
Yield 2027 *
-
Yield 2028 * -
1 day-1.09%
1 week-3.16%
Current month+7.55%
1 month+12.55%
3 months+47.53%
6 months+29.78%
1 week 21.27
Extreme 21.27
23.36
1 month 18.85
Extreme 18.85
24.43
Current year 10.65
Extreme 10.65
24.43
1 year 10.65
Extreme 10.65
24.43
3 years 10.65
Extreme 10.65
24.43
5 years 10.65
Extreme 10.65
24.43
10 years 10.65
Extreme 10.65
24.43
Date Insider Type Main position Quantity % Market Cap. Importance
7/31/26 Tax

Chief Executive Officer

-31,350 0.0112%
7/31/26 Tax

Chief Technology Officer

-8,012 0.0029%
7/31/26 Tax

General Counsel

-1,762 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
-1.09%-3.16% - - 6.12B
-0.40%-0.04%+23.22%+21.11% 12.51B
-1.05%+0.77%+11.94%+16.93% 6.52B
-0.21%+2.66%+23.70%+10.27% 5.54B
-1.53%-1.17%-20.99%+35.65% 4.99B
+0.38%+3.39%-31.74%-24.86% 3.9B
-0.18%+7.61%+28.38%-11.32% 1.94B
-1.65%-2.30%-18.13%+191.44% 1.71B
-1.95%+2.06%+45.86%-17.74% 1.57B
-2.21%+3.49%-21.60%+33.09% 1.35B
Average -0.99%+1.05%+4.52%+28.29% 4.61B
Weighted average by Cap. -0.76%+0.28%+8.46%+20.86%

Financials

2027 *2028 *
Net sales 3.44B 3B 2.83B 2.57B 4.81B 330B 4.84B 33.9B 13.08B 168B 12.91B 12.63B 540B 3.72B 3.24B 3.06B 2.78B 5.21B 357B 5.23B 36.7B 14.16B 182B 13.98B 13.67B 584B
Net income 171M 149M 141M 128M 239M 16.4B 240M 1.69B 650M 8.34B 642M 628M 26.82B 251M 219M 207M 188M 352M 24.09B 353M 2.48B 955M 12.25B 943M 922M 39.41B
Net Debt -297M -259M -245M -222M -416M -28.5B -418M -2.93B -1.13B -14.49B -1.12B -1.09B -46.63B -600M -523M -494M -449M -841M -57.59B -844M -5.92B -2.28B -29.28B -2.25B -2.2B -94.21B
Logo MiniMed Group, Inc.
MiniMed Group, Inc. is a medical technology company, which develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Its fully integrated system addresses pain points for people with diabetes (PWD): health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system. The MiniMed 780G system uses its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings. The MiniMed 780G consists of the MiniMed 780G insulin pump, the Simplera Sync CGM sensor, and the instinct sensor. Its platform of clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and a Smart Multiple Daily Injection (MDI) System. Its pipeline products are the MiniMed Flex, screenless insulin pump, next-generation Vivera dosing algorithm, and MiniMed Fit patch pump with extended wear.
Employees
-
Date Price Change Volume
26-09-18 US$21.79 -1.09% 2,881,501
26-09-17 US$22.03 -1.65% 2,730,480
26-09-16 US$22.40 +1.77% 4,068,882
26-09-15 US$22.01 +0.18% 2,127,128
26-09-14 US$21.97 -2.36% 4,386,564
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
21.79USD
Average target price
24.55USD
Spread / Average Target
+12.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MMED Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!